TotalFinaElf S.A. (TOT) : Traders are bullish on TotalFinaElf S.A. (TOT) as it has outperformed the S&P 500 by a wide margin of 3.02% in the past 4 weeks. The bullishness in the stock continues even in the near-term as the stock has returned an impressive 0.44%, relative to the S&P 500. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 0.95% in the last 1 week, and is up 2.88% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock.
The stock has recorded a 20-day Moving Average of 1.29% and the 50-Day Moving Average is 2.42%.The 200 Day SMA reached 6.82%. TOTAL S.A. is up 1.79% in the last 3-month period. Year-to-Date the stock performance stands at 12.08%.
TotalFinaElf S.A. (NYSE:TOT): After opening at $48.74, the stock dipped to an intraday low of $48.42 on Friday. However, the bulls stepped in to buy at lower levels and pushed the stock higher. The stock touched an intraday high of $49.07 and the buying power remained strong till the end. The stock closed at $48.95 for the day, a gain of 2.49% for the day session. The total traded volume was 969,633. The stocks close on the previous trading day was $47.76.
Total S.A. is an energy operator. The Company operates through three business segments: an Upstream segment, including alongside the activities of the exploration and production of hydrocarbons, the activities of gas and power; a Refining & Chemicals segment constituting an industrial hub comprising the activities of refining, petrochemicals and specialty chemicals and also includes the activities of oil trading and shipping; a Marketing & Services segment, including the global activities of supply and marketing in the field of petroleum products, as well as the activity of new energies, and a Corporate segment, which includes holdings operating and financial activities. Its projects include CLOV, EGINA, IKIKE, INCAHUASI, LAGGAN-TORMORE, OML-58 UPGRADE, EA-1 AND EA-1A (UGANDA), ELGIN – FRANKLIN REDEVELOPMENT and ABSHERON PH.1, among others.